SCHEMBL23824893

SCHEMBL23824893

CCOC(=O)c1ccc(C=NS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ GAA P10253 1/20 0.59
▸ POLB P06746 2/20 0.56
▸ CA2 P00918 2/20 0.51
▸ CA9 Q16790 2/20 0.51
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ ESR2 Q92731 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ RECQL P46063 1/20 0.45
▸ STS P08842 1/20 0.45
▸ NHERF1 O14745 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21964114 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL21964173 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL21964113 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL21964172 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL10073012 0.81 ALDH1A1 (0.78) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL307938 0.81 ALDH1A1 (0.78) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL16802983 0.81 ALDH1A1 (0.78) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL12444207 0.80 ALDH1A1 (0.64) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL10047304 0.80 ALDH1A1 (0.64) ALDH1A1KMT2AGAAPOLBCA2
SCHEMBL12515615 0.80 ALDH1A1 (0.72) ALDH1A1KMT2AGAAPOLBCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098155-A1 NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) 2022-03-31 — — US disclosed
EP-3880662-A1 NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 Universite de Rouen Normandie (FR) 2021-09-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220098155-A1 NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 SSTR5, SLC6A15, SLC1A5 ALDH1A1 2836/4885KMT2A 2417/4885GAA 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback